A viral report claims GLP-1 social media content is fueling teen eating disorders. Dr Yoni Freedhoff checked the literature and found that the data tell a different story.

Dr. Yoni Freedhoff on what having a "best weight" actually means

Recent headlines have alarmingly stated dramatic muscle loss for patients on GLP-1s. Yoni Freedhoff, MD, explains why this is a manufactured controversy.

Does the new generation of weight-loss drugs mark the end for weight-loss diet researchers, fat-acceptance entrepreneurs, and others? Yoni Freedhoff, MD, thinks it does.

Two recent developments may potentially increase GLP-1 coverage for more patients with obesity. The lack of coverage may be another failure of recognizing obesity as a chronic disease.

Recent reports show a decrease in obesity rates; however, a new proposed definition predicts a surge of people with obesity.

YouTube video by StandWithUs Canada

Yoni Freedhoff, MD, reviews the new book 'Food Intelligence,' which details the impact of food on nutrition, biochemistry, metabolism, and health.

Lilly announces the pending launch of their MyZepbound.ca financial assistance program for patients prescribed tirzepatide for obesity

Introduction Public health environmental surveillance has evolved, especially during the coronavirus pandemic, with wastewater-based surveillance being a prominent example. As surveillance methods exp...

If You Have Obesity, You'll Pay Nearly Double For Mounjaro Than If You Have Diabetes

Recent studies offer a grim view of obesity treatment, however, they fail to acknowledge the current generation of obesity medications. Yoni Freedhoff, MD, explains why this is problematic.

Jewish doctors are quitting the profession in Canada, as racist hate has overtaken hospitals & universities since October 7. What can be done to stop blackballing--& restore decency in health care?

If you're prescribed tirzepatide for obesity in Canada, come January, you'll be paying double what you would pay if you were prescribed it for type 2 diabetes